GSK3196165

GlaxoSmithKline’s rheumatoid arthritis prospect misses phase 2 endpoint
Fierce Pharma
Mon, 10/22/18 - 05:15 pm
GSK
rheumatoid arthritis
GSK3196165
clinical trials